Data / Research funding / Lyme Disease
Lyme Disease: 158 NIH awards ($211.5M) to 74 organizations
158 NIH awards ($211.5M) in the NIH spending category Lyme Disease, to 74 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
158 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Vermont Biomedical Research Network-Vermont INBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,534,463 | September 30, 2001 | June 30, 2030 | FRANCKLYN, CHRISTOPHER S | reporter.nih.gov |
| Lyme Disease: B cell epitope discovery and mechanisms of antibody protection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,722,146 | September 16, 2019 | September 15, 2024 | MANTIS, NICHOLAS J. | reporter.nih.gov |
| Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,573,382 | September 1, 2021 | August 31, 2027 | NIGROVIC, LISE E. | reporter.nih.gov |
| DNA damage response and repair of a broken chromosome | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,083,668 | June 1, 2018 | May 31, 2028 | HABER, JAMES E | reporter.nih.gov |
| Evaluation of an OMV-adjuvanted Chimeritrope Vaccine against Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $4,961,891 | September 30, 2018 | September 29, 2023 | MORICI, LISA | reporter.nih.gov |
| Heritable immunization of the white-footed mouse reservoir of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,657,626 | September 1, 2021 | August 31, 2026 | ESVELT, KEVIN | reporter.nih.gov |
| Development of the INI-4001 and INI-2002 adjuvants within the context of a vaccine to prevent Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $4,583,801 | September 30, 2018 | September 29, 2024 | EVANS, JAY | reporter.nih.gov |
| Innovations in Functional B Cell Epitope Discovery for Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $4,031,164 | September 16, 2024 | September 15, 2026 | MANTIS, NICHOLAS | reporter.nih.gov |
| The Tick Immune Response During Microbial Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,501,084 | December 1, 2015 | May 31, 2027 | PEDRA, JOAO | reporter.nih.gov |
| Microbial Determinants of Excessive Inflammation and Severe Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,315,179 | September 19, 2025 | August 31, 2029 | STRLE, KLEMEN | reporter.nih.gov |
| A novel Lyme disease vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,240,479 | June 7, 2022 | May 31, 2027 | FIKRIG, EROL | reporter.nih.gov |
| Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,201,446 | May 15, 2020 | April 30, 2026 | HU, LINDEN T | reporter.nih.gov |
| A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,023,104 | June 24, 2020 | June 30, 2025 | ARNABOLDI, PAUL MICHAEL | reporter.nih.gov |
| DEVELOPMENT OF COVALENTLY BOUND HYALURONIC ACID AS AN ADJUVANT FOR MULTIVALENT LYME DISEASE VACCINE | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,999,999 | September 30, 2024 | September 29, 2027 | PETILLO, PETER A | reporter.nih.gov |
| Intranasal Vaccine Against Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,988,409 | July 12, 2022 | June 30, 2026 | GOMES-SOLECKI, MARIA | reporter.nih.gov |
| The roles of Lyme spirochete adhesins in hematogenous dissemination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,886,252 | February 10, 2022 | January 31, 2027 | COBURN, JENIFER L | reporter.nih.gov |
| Structure-Function Relationships in the Spirochetal Flagellar Motor | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,865,323 | February 15, 2010 | May 31, 2027 | LIU, JUN | reporter.nih.gov |
| Multivalent Tick-Microbe targeted Lyme disease vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,836,037 | July 20, 2020 | June 30, 2027 | PAL, UTPAL | reporter.nih.gov |
| Genetic architecture of host response to tickborne disease in Peromyscus leucopus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,831,395 | September 17, 2020 | August 31, 2025 | LONG, ANTHONY DOUGLAS | reporter.nih.gov |
| Hybrid ELISA: Simple and specific one-tier assay for Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,764,666 | March 6, 2019 | August 31, 2027 | LEVIN, ANDREW E. | reporter.nih.gov |
| Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,734,150 | June 9, 2020 | May 31, 2026 | YANG, X. FRANK | reporter.nih.gov |
| Host Metabolic Biosignatures for the Diagnosis of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,695,774 | June 19, 2019 | May 31, 2025 | BELISLE, JOHN T | reporter.nih.gov |
| Regulatory Pathways in Borrelial Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,694,240 | August 5, 2022 | July 31, 2027 | SKARE, JON T | reporter.nih.gov |
| Toward novel therapies against Lyme disease through the inhibition of lysinoalaine cross-linking in the bacterial flagella. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,405,876 | August 16, 2021 | July 31, 2025 | CRANE, BRIAN R | reporter.nih.gov |
| Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,344,769 | September 8, 2020 | August 31, 2025 | HU, LINDEN T | reporter.nih.gov |
| Virulence Mechanisms of Multifunctional Borrelial Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,337,463 | June 15, 2020 | August 16, 2024 | GARCIA, BRANDON LEE | reporter.nih.gov |
| Investigations of Lyme spirochete transmission as a complex network of microbial and ecological interactions | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,315,379 | September 16, 2022 | July 31, 2027 | COURET, JANNELLE | reporter.nih.gov |
| OspC and its role in defining host range and dissemination properties | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,211,024 | August 1, 2022 | July 31, 2026 | MARCONI, RICHARD T | reporter.nih.gov |
| SpoVG and PlzA Regulation of Lyme Disease Spirochete Infection Processes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,207,935 | April 1, 2020 | March 31, 2026 | STEVENSON, BRIAN | reporter.nih.gov |
| Borrelia gene products critical for natural infection cycle | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,181,619 | July 1, 2009 | July 31, 2025 | PAL, UTPAL | reporter.nih.gov |
| PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,090,540 | November 18, 2022 | October 31, 2027 | MARCONI, RICHARD T | reporter.nih.gov |
| New tools for tick-borne pathogen surveillance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,075,697 | December 8, 2022 | November 30, 2027 | OLIVER, JONATHAN D | reporter.nih.gov |
| Field trial and modeling of transmission blocking vaccine to prevent Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,072,628 | June 19, 2019 | May 31, 2025 | BROWN, GRANT D | reporter.nih.gov |
| Tick-Pathogen Interactions: Exploring the Intersection between Stress Responses and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,049,089 | July 11, 2022 | June 30, 2027 | SHAW, DANA KATHLEEN | reporter.nih.gov |
| FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $2,000,000 | July 17, 2020 | April 30, 2025 | WYCOFF, KEITH | reporter.nih.gov |
| Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,000,000 | April 2, 2024 | March 31, 2027 | SINGER, ALON | reporter.nih.gov |
| Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,972,995 | June 15, 2020 | May 31, 2024 | SINGER, ALON | reporter.nih.gov |
| A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,933,868 | July 1, 2024 | February 28, 2027 | DATTWYLER, RAYMOND JAMES | reporter.nih.gov |
| Understanding Unique Aspects of Motility and Chemotaxis in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,906,728 | September 19, 2008 | January 31, 2027 | LI, CHUNHAO CHRIS | reporter.nih.gov |
| Discovery of early immunologic biomarkers for risk of PTLDS through machine learning-assisted broad temporal profiling of humoral immune response | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,885,162 | July 7, 2023 | June 30, 2028 | WOODBURY, NEAL WALTER | reporter.nih.gov |
| Efficacy of novel reservoir-host targeted bait formulations against a tick-borne pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,875,000 | September 1, 2021 | August 31, 2026 | SESHU, JANAKIRAM | reporter.nih.gov |
| Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,872,987 | July 1, 2023 | June 30, 2028 | TAL, MICHAL CASPI | reporter.nih.gov |
| Virulence regulation by BadR in the Lyme disease spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,868,750 | March 24, 2021 | February 28, 2027 | OUYANG, ZHIMING | reporter.nih.gov |
| Determinants of Post-Treatment Phenotypes in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,868,460 | July 1, 2023 | June 30, 2028 | AUCOTT, JOHN | reporter.nih.gov |
| Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,830,220 | July 5, 2023 | June 30, 2028 | HU, LINDEN T | reporter.nih.gov |
| Antibody-mediated immunity to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,759,416 | March 8, 2021 | February 28, 2027 | BAUMGARTH, NICOLE | reporter.nih.gov |
| Cellular and humoral immunity in Lyme arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,748,421 | January 8, 2019 | June 30, 2024 | STEERE, ALLEN C | reporter.nih.gov |
| Peptide-vaccine development against Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,724,972 | May 15, 2020 | April 30, 2026 | BARBIER, MARIETTE | reporter.nih.gov |
| ImmunoPET Probes for the Imaging of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,674,600 | September 19, 2023 | July 31, 2028 | ZEGLIS, BRIAN MATTHEW | reporter.nih.gov |
| Emergence of tick borne encephalitis in North America | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,660,767 | December 12, 2018 | November 30, 2025 | TELFORD, SAM R | reporter.nih.gov |
| Immunomodulatory mechanisms of wild bird reservoir hosts that facilitate persistence of Lyme disease bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,654,992 | March 25, 2024 | January 31, 2029 | LIN, YI-PIN | reporter.nih.gov |
| Bacterial and host factors in the pathogenesis of Lyme neuroborreliosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,636,050 | June 23, 2022 | April 30, 2027 | BRISSETTE, CATHERINE AYN | reporter.nih.gov |
| Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,630,195 | September 20, 2023 | August 31, 2028 | MARVEL, CHERIE L | reporter.nih.gov |
| Molecular Genetics of Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,567,371 | January 15, 2020 | November 30, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Genetic basis for persistence of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,547,485 | September 20, 2023 | August 31, 2028 | TOKARZ, RAFAL | reporter.nih.gov |
| Delineation of unique flagellar proteins in spirochetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,479,778 | February 23, 2024 | December 31, 2028 | MOTALEB, MD A | reporter.nih.gov |
| Regulatory Network of the Lyme Disease Pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,426,161 | July 1, 2009 | May 31, 2028 | YANG, X. FRANK | reporter.nih.gov |
| Borrelia burgdorferi mitogen in development of arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,372,498 | April 1, 1993 | December 31, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,277,811 | August 1, 2023 | July 31, 2027 | BOURRET, TRAVIS J | reporter.nih.gov |
| Chimeric epitope based vaccines for tick borne infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,255,844 | July 24, 2019 | June 30, 2024 | MARCONI, RICHARD T | reporter.nih.gov |
| SCH: Machine LEarning & MicrofluiDics for Multimodal Sensing of TiCk-bOrne Diseases(MEDICO) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,194,187 | September 13, 2022 | August 31, 2027 | SRIVASTAVA, SOUMYA K | reporter.nih.gov |
| RpoS Regulation of Borrelia burgdorferi Genes in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,187,520 | April 1, 1990 | August 31, 2024 | RADOLF, JUSTIN D | reporter.nih.gov |
| Development of Paratransgenic Ticks for Disease Control | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,106,078 | July 1, 2002 | November 30, 2024 | MUNDERLOH, ULRIKE GERTRUD | reporter.nih.gov |
| Phage-mediated horizontal gene transfer in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,101,178 | July 25, 2024 | June 30, 2029 | SECOR, PATRICK R | reporter.nih.gov |
| The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,073,058 | June 15, 2023 | May 31, 2028 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,053,949 | August 1, 2024 | July 31, 2027 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Phylogeographic dynamics of tick-borne pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $935,188 | June 1, 2020 | May 31, 2025 | BRISSON, DUSTIN | reporter.nih.gov |
| Determination of the genetic basis for B. burgdorferi mammalian infectivity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $931,524 | June 1, 2013 | May 31, 2025 | JEWETT, MOLLIE W | reporter.nih.gov |
| Regulation of glycerol utilization in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $877,496 | June 8, 2018 | May 31, 2024 | SAMUELS, D. SCOTT | reporter.nih.gov |
| Pathogenesis of Borrelia miyamotoi infection and Lyme coinfection in mice | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $837,500 | December 1, 2017 | November 30, 2022 | BOCKENSTEDT, LINDA K. | reporter.nih.gov |
| Characterization of innate immune signaling pathways in the tick Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $831,622 | March 1, 2025 | February 28, 2030 | PERRIMON, NORBERT | reporter.nih.gov |
| Control of bacterial infections by a horizontally acquired host peptidoglycan amidase | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $795,640 | January 14, 2019 | December 31, 2022 | PANNING, BARBARA | reporter.nih.gov |
| Interactions of tick-borne pathogens, Borrelia burgdorferi and Babesia microti with the mammalian host using rodent model of co-infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $785,000 | August 9, 2019 | July 31, 2025 | PARVEEN, NIKHAT | reporter.nih.gov |
| Functional and Mechanistic Studies of the Role of Lp17-encoded Factors in Host Adaptation by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $765,000 | July 12, 2024 | June 30, 2029 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Outer Membrane Proteins of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $736,700 | January 1, 2005 | December 31, 2023 | AKINS, DARRIN R. | reporter.nih.gov |
| Antibody-mediated immunity to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $673,407 | March 8, 2021 | October 1, 2022 | BAUMGARTH, NICOLE | reporter.nih.gov |
| Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $661,519 | April 1, 2017 | March 31, 2023 | HU, LINDEN T | reporter.nih.gov |
| Deciphering Borrelia burgdorferi RpoS regulatory networks in ticks and mammals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $640,129 | September 1, 2025 | August 31, 2030 | CAIMANO, MELISSA J | reporter.nih.gov |
| Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $600,000 | July 17, 2024 | June 30, 2027 | WYCOFF, KEITH | reporter.nih.gov |
| A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $599,866 | July 8, 2024 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $599,028 | August 4, 2021 | July 31, 2024 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $597,612 | May 1, 2024 | April 30, 2027 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| Virulence Mechanisms of Multifunctional Borrelial Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $594,545 | June 15, 2020 | May 31, 2026 | GARCIA, BRANDON LEE | reporter.nih.gov |
| Low-cost Production of a Vaccine for Lyme Disease in Maize | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $593,524 | March 2, 2021 | February 29, 2024 | EGELKROUT, ERIN | reporter.nih.gov |
| The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $561,872 | June 15, 2023 | June 15, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| A cross-species signaling system in tick immunity and development | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $518,099 | July 17, 2025 | June 30, 2030 | PAL, UTPAL | reporter.nih.gov |
| Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $512,455 | August 2, 2023 | July 31, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Global virulence regulatory network in the Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $509,130 | January 2, 2025 | December 31, 2029 | OUYANG, ZHIMING | reporter.nih.gov |
| Borrelia burgdorferi-Induced Autoimmunity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $503,943 | June 1, 2013 | December 31, 2022 | STEERE, ALLEN C | reporter.nih.gov |
| Microbial Determinants of Clinical Heterogeneity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $499,998 | July 24, 2020 | July 31, 2024 | LEMIEUX, JACOB ERIC | reporter.nih.gov |
| Establishing CRISPR cell screening for the deer tick Ixodes scapularis, a vector of Lyme and other diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $468,950 | August 18, 2022 | July 31, 2024 | PERRIMON, NORBERT | reporter.nih.gov |
| Microfluidic Assays for Probing Neutrophil-Borrelia Interactions in Blood during Acute Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $462,000 | April 1, 2021 | March 31, 2024 | IRIMIA, DANIEL | reporter.nih.gov |
| The Role the AAA+ Lon Proteases in Bacterial Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $461,823 | June 1, 2017 | May 31, 2024 | KARZAI, A. WALI | reporter.nih.gov |
| Systematic identification of interactions between Lyme Borrelia and Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $461,375 | July 1, 2025 | June 30, 2027 | FIKRIG, EROL | reporter.nih.gov |
| Immunophenotypic analysis of the cutaneous humoral response in early Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $460,625 | February 3, 2022 | January 31, 2024 | BOCKENSTEDT, LINDA K. | reporter.nih.gov |
| Contribution of RpoS to persistence of Borrelia burgdorferi in mammals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $457,875 | July 1, 2025 | June 30, 2027 | CAIMANO, MELISSA J | reporter.nih.gov |
| Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $456,886 | June 1, 2023 | May 31, 2026 | CAIMANO, MELISSA J | reporter.nih.gov |
| Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $440,941 | March 11, 2021 | February 29, 2024 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Identification of stage-and tissue-specific endogenous tick promoters | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $439,000 | August 1, 2023 | July 31, 2025 | GULIA-NUSS, MONIKA | reporter.nih.gov |
| Activation of T gamma/delta cells by Borrelia glycolipids | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $438,625 | June 4, 2021 | May 31, 2024 | BENACH, JORGE L. | reporter.nih.gov |
| Protease sensor for rapid and sensitive detection of Borrelia infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $436,236 | August 1, 2025 | July 31, 2027 | BOGYO, MATTHEW | reporter.nih.gov |
| The Role of YebC in persistent infection of the Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $435,875 | May 16, 2022 | April 30, 2025 | YANG, X. FRANK | reporter.nih.gov |
| Characterizing the Pan-genome of a Rickettsia Infecting the Eastern Black-legged Tick | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $435,228 | January 22, 2021 | December 31, 2022 | GILLESPIE, JOSEPH J | reporter.nih.gov |
| Basic immunological toolbox for genus Peromsycus, infection tolerant reservoirs of zoonotic agents | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $431,750 | July 1, 2025 | June 30, 2027 | BARBOUR, ALAN G. | reporter.nih.gov |
| Effect of Borrelia burgdorferi-SIRPalpha Interaction on the Immune Response | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $429,000 | July 17, 2025 | June 30, 2027 | COBURN, JENIFER L | reporter.nih.gov |
| Role of Borrelia Lpt Homologs in Surface Lipoprotein Secretion | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $426,250 | June 23, 2023 | May 31, 2026 | ZUECKERT, WOLFRAM R | reporter.nih.gov |
| Regulation of Skin Immunity by a Tick Bite | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $424,875 | November 1, 2021 | October 31, 2024 | PEDRA, JOAO | reporter.nih.gov |
| Role of Tick Metalloprotease Inhibitors in the Transmission of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $423,106 | August 1, 2025 | July 31, 2027 | MULENGA, ALBERT | reporter.nih.gov |
| Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | December 9, 2020 | November 30, 2023 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Functional and Mechanistic Studies of the VlsE-mediated Immune Avoidance System in the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | March 13, 2021 | February 29, 2024 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $420,750 | March 16, 2021 | February 29, 2024 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Adaptation of an in vitro generated human skin model for tick feeding to study Borrelia burgdorferi transmission and colonization | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $417,845 | August 1, 2025 | July 31, 2027 | BRINKWORTH, AMANDA J. | reporter.nih.gov |
| A novel antimicrobial resistance mechanism for Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $416,625 | August 1, 2022 | July 31, 2025 | SKARE, JON T | reporter.nih.gov |
| Enrichment and validation of urine and serum-specific antigens from acute Lyme disease patient samples | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $416,448 | December 10, 2021 | November 30, 2024 | AUCOIN, DAVID P | reporter.nih.gov |
| A murine model of Lyme neuroborreliosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $414,292 | July 1, 2024 | June 30, 2027 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Pathogen-host interactions in Lyme disease interrogated at Single Cell Level | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $412,500 | April 8, 2021 | March 31, 2024 | SESHU, JANAKIRAM | reporter.nih.gov |
| Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $411,941 | August 16, 2023 | July 31, 2025 | COMUNALE, MARY ANN | reporter.nih.gov |
| Analysis of the DksA regulon in the Lyme disease spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $411,125 | March 19, 2021 | February 29, 2024 | OUYANG, ZHIMING | reporter.nih.gov |
| Elucidating the Bacterial and Host Mechanisms Governing B. burgdorferi-Related Type I Interferon Responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $408,694 | September 15, 2021 | August 31, 2025 | HYDE, JENNY A. | reporter.nih.gov |
| Retrotransposon assay for tick host bloodmeal identification | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $407,800 | August 6, 2018 | July 31, 2023 | TELFORD, SAM R | reporter.nih.gov |
| Impacts of Borrelia burgdorferi Gac protein on infectivity and regulation of virulence protein expression | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $405,746 | June 1, 2024 | April 30, 2027 | STEVENSON, BRIAN | reporter.nih.gov |
| Identifying novel tick attractants and repellents by exploiting their olfactory and eco-physiology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $378,500 | June 7, 2021 | May 31, 2025 | SYED, ZAINULABEUDDIN | reporter.nih.gov |
| Mechanisms of Reverse Transendothelial Migration in Arthritis Resolution | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $366,797 | September 24, 2024 | August 31, 2026 | BROWN, CHARLES R. | reporter.nih.gov |
| Machine learning-based development of serologic test for acute Lyme disease diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | June 4, 2021 | May 31, 2022 | KELBAUSKAS, LAIMONAS | reporter.nih.gov |
| Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $295,514 | July 1, 2020 | March 31, 2023 | GOMES-SOLECKI, MARIA | reporter.nih.gov |
| Highly-sensitive, rapid and low cost plasmonic assay platform for Lyme disease diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $259,613 | August 12, 2022 | July 31, 2024 | GUIGNON, ERNEST FITCH | reporter.nih.gov |
| A PET Radiotracer for Diagnostic and Theranostics Imaging in Lyme Disease | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $234,000 | June 1, 2020 | March 31, 2022 | ZEGLIS, BRIAN MATTHEW | reporter.nih.gov |
| Microbial genetic variation in the pathogenesis of Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $226,948 | March 1, 2020 | February 28, 2024 | LIN, YI-PIN | reporter.nih.gov |
| Lyme disease spirochete adhesion to tick cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $225,000 | February 18, 2020 | January 31, 2024 | RENTHAL, ROBERT D | reporter.nih.gov |
| Exploring the Collaborative Cross resource to identify different phenotypes of Lyme neuroborreliosis and disease-contributing genetic factors | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $223,105 | September 1, 2023 | May 31, 2024 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Early Host Responses During Co-Infection of Tick-Borne Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $205,469 | June 30, 2020 | May 31, 2023 | MACNAMARA, KATHERINE C. | reporter.nih.gov |
| Challenging the generalist paradigm: Leveraging tick chemical ecology for new control methods | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $200,625 | September 11, 2020 | August 31, 2023 | MACHTINGER, ERIKA T | reporter.nih.gov |
| Identification of the mechanism of protection against a B. burgdorferi protein CspZ for the prevention of Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $199,455 | February 1, 2020 | January 31, 2024 | LIN, YI-PIN | reporter.nih.gov |
| Functional Impact of Stress Granules on Tick-Microbe Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $198,798 | June 9, 2020 | May 31, 2022 | SHAW, DANA KATHLEEN | reporter.nih.gov |
| Spatial case-control studies to target the human ecology of tick-borne infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $194,029 | June 10, 2020 | May 31, 2024 | LOVER, ANDREW A | reporter.nih.gov |
| MHC class II presentation of Borrelia burgdorferi and synovial tissue antigens in murine Lyme arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $192,500 | January 17, 2020 | December 31, 2022 | LOCHHEAD, ROBERT | reporter.nih.gov |
| Mechanisms of central nervous system invasion by the Lyme disease spirochete, Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $192,500 | April 8, 2025 | March 31, 2027 | CASSELLI, TIMOTHY | reporter.nih.gov |
| Mechanistic Studies of the Role of Genetic Factors in VlsE Antigenic Variation by the Lyme Disease Spirochete | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $191,250 | January 1, 2025 | December 31, 2026 | BANKHEAD, TROY MICHAEL | reporter.nih.gov |
| Regulation of infection-associated protein expressed by the Lyme disease spirochete DnaA protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $184,332 | February 14, 2020 | January 31, 2024 | STEVENSON, BRIAN | reporter.nih.gov |
| FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $181,737 | July 17, 2020 | June 30, 2022 | WYCOFF, KEITH | reporter.nih.gov |
| Targeting a ubiquitous spirochete bacteriophage to prevent Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $181,250 | March 10, 2020 | February 28, 2022 | SECOR, PATRICK R | reporter.nih.gov |
| Exploring the Collaborative Cross resource to identify different phenotypes of Lyme neuroborreliosis and disease-contributing genetic factors | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $177,351 | September 1, 2024 | August 31, 2025 | ROGOVSKY, ARTEM S | reporter.nih.gov |
| Novel application of isoxazoline veterinary drugs to streamline reservoir-targeted abatement of tick-borne zoonoses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $174,610 | September 1, 2020 | August 31, 2023 | VAUGHAN, JEFFERSON ARCHER | reporter.nih.gov |
| Synovium Immunoprivilege and the Modulation of Resident Synovial Macrophage Functions in Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $167,076 | May 15, 2025 | April 30, 2030 | CYNDARI, KAREN I | reporter.nih.gov |
| Development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $165,000 | July 1, 2025 | June 30, 2027 | CAMILLI, ANDREW | reporter.nih.gov |
| EGF as an environmental cue of B. burgdorferi gene regulation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $162,000 | May 5, 2025 | April 30, 2027 | HART, THOMAS | reporter.nih.gov |
| A small RNA regulation of virulence in Lyme disease pathogen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $154,500 | September 1, 2021 | August 31, 2023 | YANG, XIULI | reporter.nih.gov |
| Efferocytosis in Lyme Arthritis Resolution | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $151,930 | February 14, 2020 | June 30, 2022 | BROWN, CHARLES R. | reporter.nih.gov |
| Phage-mediated horizontal gene transfer in Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $144,559 | July 25, 2024 | August 9, 2024 | SECOR, PATRICK R | reporter.nih.gov |
| Identifying Determinants of Borrelia burgdorferi and Peromyscus leucopus symbiosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $143,365 | August 1, 2023 | August 2, 2025 | BOURGEOIS, JEFFREY | reporter.nih.gov |
| Isothermal Titration Calorimeter | NIH | Office of the Director, National Institutes of Health | 2024 | $143,119 | July 15, 2024 | April 15, 2025 | HUGHES, TRAVIS SHANE | reporter.nih.gov |
| Identification of linear plasmid lp36-encoded virulence determinants in the Lyme disease spirochete Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $141,000 | November 1, 2021 | October 31, 2024 | CASSELLI, TIMOTHY | reporter.nih.gov |
| Microbial Determinants of Clinical Heterogeneity in Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $136,350 | July 24, 2020 | June 30, 2022 | LEMIEUX, JACOB ERIC | reporter.nih.gov |
| Application of parallel PCR and DNA sequencing for detecting remnant host DNA from the prior blood meal of Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $115,424 | March 8, 2021 | February 28, 2025 | LANDESMAN, WILLIAM | reporter.nih.gov |
| Overlooked No More: Discovering Pathogens in a National Tick Collection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $74,800 | February 25, 2020 | January 31, 2022 | LITTLE, SUSAN E | reporter.nih.gov |
| B. burgdorferi interactions with the blood-CSF barrier: Development of a 3D choroid plexus organoid | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $70,500 | November 15, 2024 | October 31, 2026 | BRISSETTE, CATHERINE AYN | reporter.nih.gov |
| Characterization of a Lipid Receptor in Tick Humoral Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $40,662 | April 1, 2020 | March 31, 2022 | O’NEAL, ANYA JOSEPHINE | reporter.nih.gov |
| Application of parallel PCR and DNA sequencing for detecting remnant host DNA from the prior blood meal of Ixodes scapularis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $18,795 | March 8, 2021 | June 30, 2021 | LANDESMAN, WILLIAM | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 65 | $42,150,299 | 0 | $0 |
| 2024 | 66 | $40,321,785 | 0 | $0 |
| 2023 | 66 | $39,411,088 | 0 | $0 |
| 2022 | 76 | $46,830,173 | 0 | $0 |
| 2021 | 79 | $42,799,799 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 144 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 144 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 144 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.